Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Romanos

Showing results (211-220 of 227) with videos related to

Pageof 23
Sort By:
Comprehensive Psychiatry|March 6, 2022
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorderElvira Tini, Lukasz Smigielski, Marcel Romanos, et al.
European Child & Adolescent Psychiatry|July 20, 2024
The impact of the COVID-19 pandemic on administrative eating disorder prevalence in the outpatient sector and on severity of anorexia nervosaFriederike I Tam, Richard Ochmann, Jörg Marschall, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 25, 2010
Case-control genome-wide association study of attention-deficit/hyperactivity disorderBenjamin M Neale, Sarah Medland, Stephan Ripke, et al.
Pharmaceutics|September 28, 2023
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL TrialMichael Frey, Lukasz Smigielski, Elvira Tini, et al.
Molecular Psychiatry|August 18, 2018
Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencingJordi Corominas, Marieke Klein, Tetyana Zayats, et al.
Brain Sciences|February 13, 2021
EEG Data Quality: Determinants and Impact in a Multicenter Study of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)Anna Kaiser, Pascal-M Aggensteiner, Martin Holtmann, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort studyHelge Hebestreit, Cornelia Zeidler, Christopher Schippers, et al.
Translational Psychiatry|February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypesMichael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 21, 2011
Genome-wide association study in German patients with attention deficit/hyperactivity disorderAnke Hinney, André Scherag, Ivonne Jarick, et al.
The American Journal of Psychiatry|April 20, 2013
High loading of polygenic risk for ADHD in children with comorbid aggressionMarian L Hamshere, Kate Langley, Joanna Martin, et al.
Pageof 23

Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
Comprehensive Psychiatry|March 6, 2022
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorderElvira Tini, Lukasz Smigielski, Marcel Romanos, et al.
European Child & Adolescent Psychiatry|July 20, 2024
The impact of the COVID-19 pandemic on administrative eating disorder prevalence in the outpatient sector and on severity of anorexia nervosaFriederike I Tam, Richard Ochmann, Jörg Marschall, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 25, 2010
Case-control genome-wide association study of attention-deficit/hyperactivity disorderBenjamin M Neale, Sarah Medland, Stephan Ripke, et al.
Pharmaceutics|September 28, 2023
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL TrialMichael Frey, Lukasz Smigielski, Elvira Tini, et al.
Molecular Psychiatry|August 18, 2018
Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencingJordi Corominas, Marieke Klein, Tetyana Zayats, et al.
Brain Sciences|February 13, 2021
EEG Data Quality: Determinants and Impact in a Multicenter Study of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)Anna Kaiser, Pascal-M Aggensteiner, Martin Holtmann, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort studyHelge Hebestreit, Cornelia Zeidler, Christopher Schippers, et al.
Translational Psychiatry|February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypesMichael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 21, 2011
Genome-wide association study in German patients with attention deficit/hyperactivity disorderAnke Hinney, André Scherag, Ivonne Jarick, et al.
The American Journal of Psychiatry|April 20, 2013
High loading of polygenic risk for ADHD in children with comorbid aggressionMarian L Hamshere, Kate Langley, Joanna Martin, et al.
Pageof 23